Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thrombolytic agents].

K Furukawa

    Nihon Geka Gakkai Zasshi
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    A combination therapy of batroxobin, lysyl-plasminogen, and urokinase significantly improved deep venous thrombosis treatment compared to urokinase alone. This enhanced efficacy is linked to reduced fibrinogen and improved urokinase activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension.

    Hypertension (Dallas, Tex. : 1979)·1995
    Same author

    The effects of the site-directed removal of N-glycosylation sites from beta-1,4-N-acetylgalactosaminyltransferase on its function.

    The Biochemical journal·1995
    Same author

    Analysis of melanoma cells stably transfected with beta 1,4GalNAc transferase (GM2/GD2 synthase) cDNA: relative glycosyltransferase levels play a dominant role in determining ganglioside expression.

    Archives of biochemistry and biophysics·1995
    Same author

    Functional analysis of the threonine- and serine-rich Gp-I domain of glucoamylase I from Aspergillus awamori var. kawachi.

    Applied and environmental microbiology·1995
    Same author

    Comparison of specific reactivity of monoclonal and polyclonal ABH reactive antibodies.

    Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992
    Same author

    A novel method for blood group typing with the aid of monoclonal antibody immobilized dyed microspheres.

    Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992

    Area of Science:

    • Thrombosis and Hemostasis
    • Pharmacology
    • Vascular Medicine

    Context:

    • Deep venous thrombosis (DVT) poses significant clinical challenges.
    • Current thrombolytic therapies have limitations in efficacy and safety.
    • Optimizing thrombolytic strategies is crucial for patient outcomes.

    Purpose:

    • To evaluate the clinical efficacy of a combination therapy involving batroxobin, lysyl-plasminogen, and urokinase for deep venous thrombosis.
    • To compare the efficacy of this combination therapy against urokinase monotherapy.
    • To investigate the underlying mechanisms of enhanced thrombolysis.

    Summary:

    • A combination of batroxobin, lysyl-plasminogen, and urokinase demonstrated superior clinical efficacy in treating deep venous thrombosis compared to urokinase alone, assessed by venography and clinical improvement.

    Related Experiment Videos

  • Batroxobin infusion significantly reduced plasma fibrinogen, plasminogen, and alpha 2-plasmin inhibitor levels.
  • Fibrinolytic activity was observed in 89% of samples after combination therapy, suggesting enhanced urokinase effectiveness.

    • Impact:

    • The findings suggest a synergistic effect, where batroxobin and lysyl-plasminogen create favorable conditions for urokinase-induced fibrinolysis.
    • This combination therapy may offer a more effective treatment option for deep venous thrombosis.
    • Understanding these interactions can guide the development of improved thrombolytic regimens.